StockData
Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc. (FULC) stock

FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$3.75+0.04 (+1.08%)

Close on Nov 17, 2026Market cap $286.12MP/E –Yield –

Fulcrum Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Fulcrum Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$65.78M. For fiscal 2025 it was -$60.07M. The highest annual figure on record is -$2.22M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$60.07M–
FY2024Dec 31, 2024-$2.22M–
FY2023Dec 31, 2023-$90.97M–
FY2022Dec 31, 2022-$97.05M–
FY2021Dec 31, 2021-$78.48M–
FY2020Dec 31, 2020-$53.66M–
FY2019Dec 31, 2019-$39.48M–
FY2018Dec 31, 2018-$22.56M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.04M–
Q1 FY2026Mar 31, 2026-$18.75M–
Q4 FY2025Dec 31, 2025-$16.80M–
Q3 FY2025Sep 30, 2025-$14.19M–
Q2 FY2025Jun 30, 2025-$13.82M-123.5%
Q1 FY2025Mar 31, 2025-$15.26M–
Q4 FY2024Dec 31, 2024-$16.76M–
Q3 FY2024Sep 30, 2024-$19.07M–
Q2 FY2024Jun 30, 2024$58.90M–
Q1 FY2024Mar 31, 2024-$25.28M–
Q4 FY2023Dec 31, 2023-$23.16M–
Q3 FY2023Sep 30, 2023-$22.91M–
Q2 FY2023Jun 30, 2023-$20.79M–
Q1 FY2023Mar 31, 2023-$24.12M–
Q4 FY2022Dec 31, 2022-$19.70M–
Q3 FY2022Sep 30, 2022-$27.88M–
Q2 FY2022Jun 30, 2022-$27.37M–
Q1 FY2022Mar 31, 2022-$22.11M–
Q4 FY2021Dec 31, 2021-$21.86M–
Q3 FY2021Sep 30, 2021-$22.57M–
Q2 FY2021Jun 30, 2021-$17.82M–
Q1 FY2021Mar 31, 2021-$16.23M–
Q4 FY2020Dec 31, 2020-$19.83M–
Q3 FY2020Sep 30, 2020-$4.50M–
Q2 FY2020Jun 30, 2020-$14.12M–
Q1 FY2020Mar 31, 2020-$15.20M–
Q4 FY2019Dec 31, 2019-$4.50M–
Q3 FY2019Sep 30, 2019-$13.02M–
Q2 FY2019Jun 30, 2019-$12.07M–
Q1 FY2019Mar 31, 2019-$9.90M–
Q4 FY2018Dec 31, 2018-$6.40M–
Q3 FY2018Sep 30, 2018-$4.12M–

More Fulcrum Therapeutics figures

See a number that looks wrong?